Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Phio Pharmaceuticals (PHIO)

Annual Return

Over the past 3 years, PHIO has had an average annual return of +0%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, PHIO has had an average annual return of +0%, underperforming the benchmark SPY, which returned +12.73% annual.

Over the past 10 years, PHIO has had an average annual return of -67.20%, underperforming the benchmark SPY, which returned +15.04% annual.

Since May 10, 2012, PHIO has had an average annual return of -60.32%, underperforming the benchmark SPY, which returned +14.75% annual.

20222021202020192018201720162015201420132012
+0%+0%-75.00%-50.00%-94.41%-21.86%-81.31%-76.14%-44.82%+38.09%-46.15%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2022+0%+0%+0%
2021+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%
2020+0%-75.00%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%-75.00%
2019+12.50%+11.11%+20%+8.33%-15.38%-9.09%+0%-20.00%-12.50%-14.29%-33.33%+0%-50.00%
2018-25.17%-32.71%+15.28%-21.69%-4.62%-20.97%-22.45%+5.26%-25.00%-63.33%-27.27%+0%-94.41%
2017-11.48%+7.41%+19.54%-20.19%-14.46%+5.63%+4%-6.41%-15.75%+13.82%+15%-11.18%-21.86%

Drawdown analysis of Phio Pharmaceuticals (PHIO)

The maximum drawdown for the PHIO was -100.00%, occurring on Feb 11, 2020. This drawdown has not yet recovered.

The current PHIO drawdown is -100.00%.

Since May 10, 2012 PHIO has experienced the following drawdowns:

  • 50% or more: 3 times
  • 40% or more: 3 times
  • 30% or more: 3 times
  • 20% or more: 3 times
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-100.00%Mar 14, 20131740Feb 11, 2020OngoingOngoingOngoing
-92.73%Jul 5, 20128Jul 17, 2012161Mar 11, 2013169
-56.25%May 14, 201211May 30, 201224Jul 3, 201235
-11.11%Mar 11, 20131Mar 12, 20131Mar 13, 20132